Pharmacokinetics of fluorouracil bolus (5-fu)

Clinical trials for Pharmacokinetics of fluorouracil bolus (5-fu) explained in plain language.

Never miss a new study

Get alerted when new Pharmacokinetics of fluorouracil bolus (5-fu) trials appear

Sign up with your email to follow new studies for Pharmacokinetics of fluorouracil bolus (5-fu), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo shows promise for hard-to-treat stomach cancer

Disease control Ongoing

This study tests a drug called zolbetuximab that targets a protein (CLDN18.2) found in many stomach and gastroesophageal junction tumors. The drug is given alone or with chemotherapy and/or immunotherapy to see how well it controls tumor growth. The study includes 143 adults with…

Matched conditions: PHARMACOKINETICS OF FLUOROURACIL BOLUS (5-FU)

Phase 2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control

Last updated Sep 02, 2026 00:00 UTC

Pharmacokinetics of fluorouracil bolus (5-fu)

Get alerted when new Pharmacokinetics of fluorouracil bolus (5-fu) trials appear

New drug combo shows promise for hard-to-treat stomach cancer